La OMS respalda el uso de terapias con GLP-1 para la obesidad

Ver La OMS respalda el uso de terapias con GLP-1 para la obesidad - EL PAÍS en Dailymotion

Transcript

00:00Today, we're issuing new recommendations on the youth of GLP-1S to treat obesity in adults.

00:09These new medicines are a powerful clinical tool, offering hope to millions.

00:16But let me be clear, medication alone will not solve the obesity crisis.

00:22Obesity is a complex disease that requires comprehensive lifelong care.

00:27And it has many social, commercial, and environmental determinants requiring action in many sectors, not only in the clinic.

00:38Our greatest concern is equitable access.

00:42Without concerted action, these medicines could contribute to widening the gap between the rich and poor, both between and within countries.

00:53We must work together on strategies like pool procurement and tiered pricing to make these medicines affordable for all.

01:03This guideline is a key part of WHO's acceleration plan to stop obesity.

01:10It's built on evidence and shaped by the principle of health for all, ensuring that scientific progress benefits everyone, everywhere.

01:23're going to be able to create more

01:25Gracias por ver el video.